| Patient | Franklin D. Roosevelt |
|---|---|
| Date of birth | 1964-01-30 |
| Identifiers | MRN HR-ET002-SYN; SSN (made up) 000-02-5130 |
| Document date | 2026-04-10 |
| Author | Miriam Castellanos, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New heart failure, probably with reduced ejection fraction and driven by severe hypertension, in a 62-year-old man who smokes and uses a wheelchair. Please review the echocardiogram, confirm the diagnosis and its likely cause, and guide titration of guideline-directed therapy. [S]
Urgency: Routine, within two weeks; echocardiogram booked for the morning of the consultation. [S]
Questions for the consultant:
Mr. Roosevelt is seen at the request of Dr. Brooks two weeks after presenting with breathlessness, orthopnea, and leg swelling. On sacubitril/valsartan, carvedilol, empagliflozin, and furosemide he is less breathless: he now propels his wheelchair the length of a long corridor before resting and sleeps on two pillows without waking breathless. His home weight has fallen by about 3 kg and his home blood pressures run in the 140s over 80s. He has had no chest pain or pressure at rest or with exertion, no palpitations, no syncope, and no lightheadedness on transfers. He stopped smoking on his quit date last week. His work is demanding and he wants to keep doing it. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sacubitril 24 mg / valsartan 26 mg oral tablet, one tablet by mouth twice daily | One tablet by mouth twice daily | Oral route | 2026-03-27 to 2026-04-10 | completed | S |
| Sacubitril 49 mg / valsartan 51 mg oral tablet, one tablet by mouth twice daily | One tablet by mouth twice daily | Oral route | 2026-04-10 | active | S |
| Carvedilol 3.125 mg oral tablet, one tablet by mouth twice daily with food | One tablet by mouth twice daily with food | Oral route | 2026-03-27 to 2026-04-10 | completed | S |
| Carvedilol 6.25 mg oral tablet, one tablet by mouth twice daily with food | One tablet by mouth twice daily with food | Oral route | 2026-04-10 to 2026-06-26 | completed | S |
| Spironolactone 25 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-04-10 | active | S |
| Empagliflozin 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-27 | active | S |
| Furosemide 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-27 to 2026-06-26 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-27 | active | S |
| Nicotine 21 mg/24 hr transdermal patch, apply one patch daily | Apply one patch to the skin daily | Topical route | 2026-03-27 to 2026-06-26 | completed | S |
| Ferric carboxymaltose 750 mg in 15 mL intravenous infusion, two doses one week apart | 750 mg intravenously, two doses one week apart | Intravenous route | 2026-04-10 to 2026-04-17 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Hypertensive heart disease with heart failure; synthetic modern diagnosis linked to the documented 1944 findings | active | confirmed | I11.0 | S — Synthetic active diagnosis for the teaching episode; the 1944 findings remain D. |
| Heart failure with reduced ejection fraction, NYHA class III at diagnosis | active | confirmed | I50.22 | S — Synthetic diagnosis confirmed by echocardiogram in the modern episode. |
| Nicotine dependence, cigarettes | active | confirmed | F17.210 | S — Synthetic modern diagnosis linked to documented cigarette smoking. |
| Iron deficiency anemia in heart failure, repleted with intravenous iron | resolved | confirmed | D50.9 | S — Synthetic finding that echoes the documented 1941 anemia; the modern values are S. |
| Paraplegia from a paralytic illness at age 39, historically diagnosed as poliomyelitis; cause retrospectively disputed | active | provisional | B91 | S — Synthetic modern coding of the documented diagnosis; the alternative cause remains R. |
| Prediabetes | active | confirmed | R73.03 | S — Synthetic finding from the baseline HbA1c. |
| Hyperlipidemia | active | confirmed | E78.5 | S — Synthetic finding from the baseline LDL cholesterol. |
Vital signs recorded on 2026-04-10; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and comfortable at rest in his wheelchair; speaks in full sentences |
| Neck | Jugular venous pressure 9 cm at 45 degrees |
| Lungs | Fine crackles at both bases |
| Heart | Regular rhythm, rate 84; S3; apical impulse displaced laterally |
| Extremities | 1+ symmetric edema at the ankles and shins |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-10 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-10 | Potassium [Moles/volume] in Serum or Plasma | 4.8 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.29 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-10 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-10 | Left ventricular Ejection fraction | 30 | % | 50-70% | Low | S |
Data reviewed: Today's transthoracic echocardiogram: dilated left ventricle with global hypokinesis and no regional wall motion abnormality, ejection fraction 30 percent, and no significant valve disease. Today's basic metabolic panel, the NT-proBNP, iron studies, lipid panel, HbA1c, and TSH from the referral visit. No ECG from the diagnostic workup is on file. [S]